Abstract
A route for the preparation of carborane-containing glucuronic acid derivatives is described, starting from 1,2- O-isopropylidene-α- d-glucuronolactone. The obtained compounds are potential BNCT agents ready to be tested for their uptake in selected tumor cell lines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have